Best Lymph Node Biopsy or Excision Doctors in Brooklyn, NY

Benjamin Samstein, MD is Chief of Liver Transplantation and Hepatobiliary Surgery in the Department of Surgery at NewYork-Presbyterian/Weill Cornell Medicine and Associate Professor of Surgery at Weill Cornell Medical College, Cornell University. Dr. Samstein is the Surgical Director of the Living Donor Liver Transplant Program at NYP. Dr. Samstein is a renowned pioneer in minimally invasive liver surgery and state-of-the-art laparoscopic techniques for liver cancer. Dr. Samstein is a Castle Connolly Top Doctor. Dr. Samstein heads up the multidisciplinary liver transplantation and hepatobiliary surgery team at NYP/Weill Cornell. His specialties include the most advanced laparoscopic procedures for liver cancer, benign liver tumors and hepatobiliary pancreatic disease. He has been invited to talk about minimally invasive liver surgery throughout the world. He is a member of many surgical societies including a founding member of the International Laparoscopic Liver Society (ILLS), American Society of Transplant Surgery, American Hepato-Pancreato-Biliary Association (AHPBA). He is the Chair of the Medical Advisory Board of LiveOnNY and served as the Regional representation to the Liver and Intestine Committee of UNOS from 2014 to 2016. Dr. Samstein is well-published in the field, authoring more than 40 peer-reviewed articles in prestigious medical and surgical journals, books and book chapters. Other areas of clinical expertise include hepatic adenoma, hepatic hemangioma, cholangiocarcinoma, colorectal metastasis, live donor nephrectomy, laparoscopic living donor nephrectomy, and pediatric liver and organ transplant. Dr. Samstein received his undergraduate degree from Cornell University in 1992 and earned his MD at the State University of New York at Stonybrook in 1997. He did his internship and residency in general surgery at NYP/Columbia, and completed a research fellowship at the Mayo Clinic in 2001. He completed a fellowship in ASTS Multi-organ transplant at NYP/Columbia in 2006. He was Assistant Professor of Surgery at Columbia University Medical Center from 2006 to 2015. He served as Program Director of the transplant surgery fellowship at Columbia University from 2007 to 2015. He is a reviewer for American Journal of Transplantation, Transplantation, Liver Transplantation, Pediatric Transplantation, Clinical Transplantation among other journals. List of Publications by Dr. Samstein PubMed

Dr. Gudis is dual-fellowship trained both in Rhinology: Advanced Endoscopic Sinus and Skull Base Surgery and in Pediatric Otolaryngology. Dr. Gudis treats the full spectrum of sinonasal disorders in both adults and children as well as the full spectrum of pediatric otolaryngology.

My goals are to educate you and your family about your problem and fully explain the operative and non-operative options you have to treat your condition. I am always available to my patients and our team works tirelessly to keep access and the lines of communication open. Being presented with the diagnosis of a brain tumor can be stressful, and we work hard to ensure your time with us is useful, educational, and compassionate.

Dr. Matthew Mori, MD is an Otolaryngology (Ear, Nose /amp Throat) Specialist who practices in New York, NY. He is 48 years old and has been practicing for 16 years. Dr. Matthew Mori, MD is affiliated with Mount Sinai Morningside.

Dr. Anas Rameau is an attending laryngologist at the Institute, and an Assistant Professor of Otolaryngology at Weill Cornell Medical College. She is a fellowship-trained otolaryngologist-head and neck surgeon, with advanced expertise in the evaluation and treatment of swallowing disorders, encompassing esophageal stenosis, gastro-esophageal reflux, dysmotility, sequelae of head and neck and thoracic radiation, Zenker's diverticulum and age-related dysphagia. She also has specialized training in the management of chronic cough, treatment of benign diseases and malignant tumors of the larynx, voice restoration, and airway rehabilitation surgery. Prior to joining the Institute, Dr. Rameau was an otolaryngology resident at Stanford University and then a fellow at UC Davis Medical School, under the mentorship of Peter Belafsky, MD MPH PhD.Dr. Rameau's clinical goals is to provide expert and compassionate care for patients with dysphagia both in the clinic and in the operating room, and to restore patients' swallowing function via advanced diagnostics technology, as well as refined endoscopic and surgical treatments. Her research focus is on outcomes studies of interventions for swallowing disorders, as well as preventative and restorative measures to decrease aspiration risk in patients with dementia. She is developing expertise in the use of artificial intelligence in the diagnostic streamlining of laryngological and swallowing disorders. In addition, Dr. Rameau is passionate about global health, and has maintained an active relationship with the Otolaryngology Department at the University of Zimbabwe in Harare. Dr. Rameau is a Diplomate of the American Board of Otolaryngology.

The Sean Parker Institute for the Voice, part of the Weill Cornell Medicine Department of Otolaryngology – Head and Neck Surgery, provides the highest quality of care for patients with voice disorders, whether they are performers, public speakers or other intensive voice users, or people with more routine vocal demands. Voice is essential in our personal and professional lives, but most people take it for granted. Anyone with a voice problem knows how limiting it can be; often, it is no exaggeration to call it disabling. Although voice disorders affect more than 20 million people in the United States, finding specialized care can be a challenge. The Sean Parker Institute offers expert diagnosis and sophisticated, effective treatment appropriate for each patient's vocal requirements. The institute is also committed to advancing the science of clinical care through transformative research focused on root problems in the treatment of laryngeal disease.

Dr. Raymond Chai, MD is an Otolaryngology (Ear, Nose /amp Throat) Specialist who practices in New York, NY. He is 45 years old and has been practicing for 18 years. Dr. Raymond Chai, MD is affiliated with Mount Sinai Morningside.

I am a surgical oncologist whose primary area of clinical and research interest is melanoma. In 1991, I introduced lymph-node mapping and sentinel lymph-node biopsy for melanoma and other selected skin cancers. Together, these procedures can determine during surgery whether a tumor has spread to surrounding lymph nodes. Using lymph node mapping, we can pinpoint the precise lymph node into which a nearby tumor is likely to travel first (called the sentinel node). If a biopsy of the sentinel node indicates cancer spread, the surrounding lymph nodes are removed. But if there is no evidence of cancer in the sentinel node, patients are spared from additional lymph node surgery. My research has focused primarily on detecting and defining the clinical significance of individual melanoma cells in the sentinel lymph nodes, blood, and bone marrow of melanoma patients, with the goal of identifying patients at highest risk of cancer recurrence following surgery to remove a melanoma. I served as Chief of the Gastric and Mixed Tumor Service in MSKCC's Department of Surgery from 1997 until October 2003. This service focuses primarily on the surgical management of less common malignancies, including melanoma, sarcoma, gastric cancer, and pancreatic cancer, and also provides surgical support for the Lymphoma Service. I currently serve as a co-leader of the MSKCC Melanoma Disease Management Team -- a multidisciplinary team of surgeons, medical oncologists, pathologists, and other medical professionals who specialize in the diagnosis and treatment of melanoma. On a national and international level, I am involved in advancing new ways to diagnose and treat melanoma as a member of the American Joint Commission on Cancer Melanoma Staging Committee, the National Comprehensive Cancer Network Melanoma Advisory Group, the American College of Surgeons Commission on Cancer Melanoma Working Group, the American College of Surgeons Oncology Group's Melanoma Working Group, and the World Health Organization Melanoma Committee. In addition to my interest in melanoma, I also have an expertise in the treatment of gastric cancer. I served on the program committee of the International Gastric Cancer National Meeting in 2001. And in 2002, I was co-leader of the Gastric Cancer Working Group of the National Cancer Institute's Stomach Cancer Progress Review Group. I am currently the co-principal investigator of two gastric cancer studies at MSKCC. The first evaluates the effectiveness of chemotherapy prior to surgery in high-risk gastric cancer patients, and the second is a 'Quality of Life Assessment' of gastric cancer patients. I am also an active member of the American College of Surgeons Oncology Group Upper GI Cancer Working Group. MSKCC plays a key role in training oncology doctors, and I have had a long-standing interest in the training of surgical oncology fellows. I served as the Director of Surgical Education for the Surgical Oncology Fellowship Training Program at MSKCC from 1991 to 1997, and I was Director of the Society of Surgical Oncology Training Committee, where I oversaw the administration of all surgical oncology fellowships across the nation from 1994 to 1999. As part of my interest in spreading information we have learned about cancer at MSKCC, I have lectured extensively, both nationally and internationally, and authored a number of manuscripts and reviews on various surgical oncology topics. You can view a complete listing of my publications in PubMed by clicking on the PubMed icon to the right.

I am a board-certified general surgeon and surgical oncologist with a clinical expertise in melanoma and soft tissue sarcoma. I work closely with the patient and the comprehensive team of physicians to customize treatment plans for each individual. In my research, I am investigating new ways to allow the immune system to fight cancer. I am also involved in clinical trials aimed at defining the role of current therapies and improving outcomes through novel new treatments. I am fluent in both Spanish and English.

Dr. Jennifer Lehman, MD is a General Surgery Specialist who practices in New York, NY. She is 52 years old and has been practicing for 21 years. Dr. Jennifer Lehman, MD is affiliated with Mount Sinai Morningside.

We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.

To provide expert and compassionate care for patients with benign and malignant tumors of the head and neck and thyroid gland. To expose patients to a renowned and dedicated team of clinicians from radiation oncology, medical oncology,radiology, pathology, cytology, speech and swallowing therapy, endocrinology who form a unique multidisciplinary group dedicated to providing the highest quality of patient care.